Novus Therapeutics, Inc.·4

Sep 30, 9:30 PM ET

FLESHER GREGORY J. 4

4 · Novus Therapeutics, Inc. · Filed Sep 30, 2019

Insider Transaction Report

Form 4
Period: 2019-09-26
FLESHER GREGORY J.
DirectorChief Executive Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-09-26+100,000100,000 total
    Exercise: $0.67Exp: 2029-09-26Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]This option represents a right to purchase a total of 100,000 shares of the Issuer's Common Stock, which will vest in equal installments on the first and second anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION